Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SLDB | Common Stock | Award | +584 | 584 | Dec 2, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SLDB | Stock Option (Right to Buy) | Award | $0 | +229K | $0.00 | 229K | Dec 2, 2022 | Common Stock | 229K | $6.77 | Direct | F2 | |
transaction | SLDB | Restricted Stock Units | Award | $0 | +114K | $0.00 | 114K | Dec 2, 2022 | Common Stock | 114K | Direct | F3, F4 |
Id | Content |
---|---|
F1 | The reporting person acquired 584 shares of the issuer's common stock pursuant to the issuer's acquisition of all of the outstanding capital stock of AavantiBio, Inc. on December 2, 2022. |
F2 | This option was granted on December 2, 2022 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary. |
F3 | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs"). |
F4 | The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. |